We're aiming for 100 new donors and $10,000 raised by May 31 — make your first gift today to support transparency in politics. OpenSecrets is 100% funded through donations.

11.2 Growth of Approved Average IVD Test Fee 11.3 The Most Used IVD Assays 11.4 The Highest Grossing Assays 11.5 Laboratory Fees Schedule For more information about this report visit About is the ...

The test, developed by Japan-based Fujirebio Diagnostics, uses a blood sample to detect the presence of plaques in the brain called amyloid that are thought to be linked to Alzheimer’s.

Israeli startup SpotitEarly launched in the U.S. on Thursday, aiming to close a significant gap in the cancer diagnostics market. The company is developing a breath-based early detection test for ...

Apple’s next step for CarPlay is a version you’ll only get to try if you’re a fan of luxury cruisers or a popular spy film franchise. CarPlay Ultra, with its new suite of exclusive features ...

Good morning and welcome to the Lucid Diagnostics First Quarter 2025 Business Update Conference Call. Please note, this event is being recorded. I would now like to turn the conference call over ...

Independent shop shows us why OBD diagnostics are great, but not the definite answer to every check engine light. Like the sunrise and the sunset, cars develop problems that will set off a check ...

Roche pledged a $550 million boost to its site in Indianapolis—where Roche has its diagnostics division and where fellow Big Pharma Eli Lilly is headquartered—as the Swiss company continues to beef up ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...

To address these gaps, the NIHR Rapid Service Evaluation Team (RSET) conducted a systematic scoping review of 140 studies in the international literature on AI in radiology diagnostics. We looked at ...

“The challenges of diabetes are pervasive, with millions of Americans living with the constant vigilance and countless daily decisions the disease requires,” said Brad Moore, president and CEO of ...